The Global Burden of Cardiovascular Disease in Women

Current Treatment Options in Cardiovascular Medicine
Shilpa Sharma, Malissa J Wood

Abstract

Cardiovascular disease (CVD) is the leading cause of mortality worldwide, accounting for one third of all deaths in 2015. Alarmingly, there has been slowing of the decline in age-standardized CVD mortality over the last 5 years compared to the previous 25 years. Given the increasing global CVD burden, in 2011, the United Nations declared the goal to reduce premature mortality from the four main non-communicable diseases by 25% from 2010 to 2025, abbreviated as the 25 × 25 goal. The United Nations has further created nine targets to achieve the 25 × 25 goal. These targets emphasize risk factor modification and strengthening of healthcare delivery systems. Achieving the nine targets and 25 × 25 goal set by the United Nations will undoubtedly benefit the world as a whole. However, women face additional, unacceptable, disproportionate CVD risk factors that need to be addressed, including psychological stressors contributing to ischemic heart disease, pregnancy-related CVD, environmental and infectious exposures in low socioeconomic settings, and limited healthcare access and delivery. This paper highlights global CVD gender disparities in order to stimulate awareness and discussion of potential interventions to address the rapidly ...Continue Reading

References

Jan 6, 2012·Heart·Clara K Chow, Anushka A Patel
Feb 22, 2012·Heart·Ana Olga Mocumbi, Karen Sliwa
Mar 14, 2013·Circulation·Goodarz DanaeiUNKNOWN Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group
Dec 19, 2013·Circulation·Sumeet S ChughChristopher J L Murray
Aug 15, 2014·The New England Journal of Medicine·Dariush MozaffarianUNKNOWN Global Burden of Diseases Nutrition and Chronic Diseases Expert Group
Apr 2, 2015·The New England Journal of Medicine·Gregory A RothChristopher J L Murray
Oct 28, 2015·Circulation·Gregory A RothChristopher J L Murray
Feb 24, 2016·Circulation·J D SchwalmSalim Yusuf
Jun 15, 2016·Circulation·Gene F KwanGene Bukhman
May 12, 2017·Obstetric Medicine·Peter von Dadelszen, Laura A Magee
May 22, 2017·Journal of the American College of Cardiology·Gregory A RothChristopher Murray
Aug 24, 2017·The New England Journal of Medicine·David A WatkinsGregory A Roth
Feb 21, 2018·Circulation·Adrienne O'NeilAnne Kavanagh
Mar 25, 2018·The Canadian Journal of Cardiology·Sujane Kandasamy, Sonia S Anand

❮ Previous
Next ❯

Citations

Feb 5, 2019·Climacteric : the Journal of the International Menopause Society·C A Stuenkel
Sep 25, 2021·BMC Cardiovascular Disorders·Taslima MamatazSherry L Grace

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.